Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin Dosing Protocols in Healthy Individuals (ALRx008)
NCT06301529Phase 4Completed
- Sponsor
- AgelessRx
- Start
- Feb 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of canagliflozin in aging, sponsored by AgelessRx. Started Feb 2024; status: completed.
02
Drugs
canagliflozin
03
Conditions
aging
Beyond the preview
Go deeper on NCT06301529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06301529.